发明名称 AMINOPYRIDINE AND CARBOXYPYRIDINE COMPOUNDS AS PHOSPHODIESTERASE 10 INHIBITORS
摘要 Pyridine and pyrimidine compounds: (I); or a pharmaceutically acceptable salt thereof, wherein m, n, R1, R2, R3, R4, R5, R6, R7, X1, X2, X3, X4, X5, X6, X7, X8, and Y are as defined in the specification; (II); or a pharmaceutically acceptable salt thereof, wherein ring A, m, n, y, R2, R3, R4, R5, R6, R7, R8, R9, X1, X2, and ring A are as defined in the specification; and (III); or a pharmaceutically acceptable salt thereof, wherein m, n, y, R2, R3, R4, R5, R6, R7, R9, X1, X2, and ring A are as defined in the specification; compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.
申请公布号 CA2746307(C) 申请公布日期 2013.11.19
申请号 CA20092746307 申请日期 2009.12.16
申请人 AMGEN INC. 发明人 ALLEN, JENNIFER R.;CHEN, NING;FALSEY, JAMES R.;FROHN, MICHAEL;HARRINGTON, PAUL;HU, ESSA;KALLER, MATTHEW R.;KUNZ, ROXANNE;MERCEDE, STEPHANIE J.;NGUYEN, THOMAS T.;PICKRELL, ALEXANDER J.;REICHELT, ANDREAS;RUMFELT, SHANNON;RZASA, ROBERT M.;SHAM, KELVIN;SIEGMUND, AARON C.;TEGLEY, CHRISTOPHER M.;YAO, GUOMIN
分类号 C07D213/74;A61K31/444;A61P25/18;C07D213/84;C07D401/12;C07D401/14;C07D407/14;C07D409/14;C07D413/14 主分类号 C07D213/74
代理机构 代理人
主权项
地址